STAT
SEPTEMBER 13, 2023
Over more than a decade working with immigrant farmworkers in the public clinics of the Santa Clara River Valley, Rosemary Hernandez has seen many new moms struggle during the postpartum period. Some were separated from their families in Mexico. Others’ husbands or boyfriends had to head straight back to work picking fruit after the baby arrived.
The Pharmacist
SEPTEMBER 13, 2023
YouTube has committed to expanding the categories of healthcare professionals that it verifies as a reputable source amid concerns pharmacists are currently excluded. This month the online video platform launched new content features which aim to help highlight health videos from trusted channels, including using a badge on videos from registered health creators.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 13, 2023
This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act. One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law. Unfortunately, the exemptions aren’t working as intended.
The Pharmacist
SEPTEMBER 13, 2023
Pharmacists and pharmacy teams working in general practice and primary care networks (PCNs) have been shortlisted for Cogora’s General Practice Awards 2023. Six pharmacists or pharmacy teams were shortlisted for the pharmacist / pharmacy team of the year category. And multidisciplinary teams were recognised for vaccination services and initiatives to achieve clinical improvement in mental […] The post Pharmacists shortlisted for general practice awards appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 13, 2023
In the clinic where I work, I met a patient the other day whom I might not have 20 years ago. He was from Uganda. Recently, he had moved to my small university town a few hours outside of Toronto. He was eager and bright. As we spoke, I was struck by how coolly he handled himself in the face of a great adversity. He told me that during an emergency medical procedure, in a rural village where he was doing fieldwork, he contracted HIV.
The Pharmacist
SEPTEMBER 13, 2023
A PCN in Cumbria will implement an app that talks to patients to assist them in optimising their own medicine use at home without requiring additional clinical time. Eden PCN, which supports 54,000 patients, will deploy the Aide app to help improve management of long-term conditions, including asthma, type 2 diabetes and hypertension. The plain-language […] The post PCN to use conversation app to improve medicines adherence appeared first on The Pharmacist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaVoice
SEPTEMBER 13, 2023
Tapping into our growing community for expertise and inspiration.
STAT
SEPTEMBER 13, 2023
SAN FRANCISCO — As part of one of the tech industry’s most revered venture funds, Daryl Tol is very familiar with fast-paced, sometimes overblown pitches from go-getter founders, lining up at happy hours and investor panels to score just a few minutes of face time. A chance meeting, or an email to the right person, could propel pie-in-the-sky ideas into billion-dollar, global businesses.
Med Ed 101
SEPTEMBER 13, 2023
One of the most common medication review requests I get from clinical staff in long term care and assisted living facilities is identifying medications that may be contributing to falls. Identifying low blood pressure as a potential contributing factor is usually pretty obvious. It is also obvious to reduce antihypertensive medications (ACEs, ARBs, Diuretics, Calcium […] The post Medications That Cause Low Blood Pressure (Non-Antihypertensives) appeared first on Med Ed 101.
STAT
SEPTEMBER 13, 2023
A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients. The group of independent experts voted 9-3 that the benefits of Alnylam’s drug, called patisiran, outweighed its risks for patients with ATTR-CM , a progressive disease that leads to fatal heart fail
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
SEPTEMBER 13, 2023
The biotech is telling investors it expects to launch as many as 15 new products in five years, a bold goal that will require a lot to go right to pull off.
Pharma Times
SEPTEMBER 13, 2023
Theoria technologies aims to empower those affected by dementia - News - PharmaTimes
Express Pharma
SEPTEMBER 13, 2023
Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park located at Changodar, Ahmedabad from June 5-13, 2023. The inspection was a cGMP Inspection and had ended with NIL observations. The post Zydus gets EIR for injectables manufacturing facility at Zydus Biotech Park appeared first on Express Pharma.
Pharma Times
SEPTEMBER 13, 2023
Four research innovation teams are set to receive £500,000 each - News - PharmaTimes
European Pharmaceutical Review
SEPTEMBER 13, 2023
Following a UK Medicines & Healthcare Products Regulatory Agency (MHRA) inspection, Rentschler Biopharma SE’s UK advanced therapy medicinal products (ATMP) facility has received a current good manufacturing practice (cGMP) Manufacturing Compliance Certificate. This means that the contract development and manufacturing organisation (CDMO)’s site in the Cell and Gene Therapy Catapult’s Manufacturing Innovation Centre in Stevenage, is compliant to produce adeno-associated virus (AAV) vectors fo
The Script
SEPTEMBER 13, 2023
Are you thinking about relocating for work? Rx relief weighs in with three questions you should ask yourself before relocating.
pharmaphorum
SEPTEMBER 13, 2023
Revolutionising life sciences with AI and automation: An enterprise modernisation journey Mike.
World Pharma News
SEPTEMBER 13, 2023
Scientists from the German Cancer Research Center (DKFZ) identify a new and surprising function of a membrane protein on the surface of cancer cells: It supports and stabilizes an important "co-stimulatory" factor that enhances the activation of T cells, thus improving the immune response against the tumor. The study was conducted in collaboration with researchers from the Netherlands Cancer Institute.
Pharmaceutical Technology
SEPTEMBER 13, 2023
The FDA is also reviewing a subcutaneous formulation of Takeda’s blockbuster drug for ulcerative colitis.
Outsourcing Pharma
SEPTEMBER 13, 2023
In the rapidly evolving world of pharmaceutical development, high-potency active pharmaceutical ingredients (HPAPIs) are becoming powerful tools.
Pharmaceutical Technology
SEPTEMBER 13, 2023
Eli Lilly has had its therapy Mounjaro (tirzepatide) approved for patients in England with type 2 diabetes (T2D).
Drug Channels
SEPTEMBER 13, 2023
Time for our annual update on the channels for provider-administered drugs. For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Despite the concerted efforts of insurers such as UnitedHealthcare and Elevance Health, however, buy-and-bill remains the most common channel for these products.
Pharmaceutical Commerce
SEPTEMBER 13, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
BioPharma Dive
SEPTEMBER 13, 2023
“There is a light wind for benefit, and no wind for risk,” said one adviser who voted with eight others to recommend the biotech’s drug Onpattro for cardiomyopathy of ATTR amyloidosis.
Express Pharma
SEPTEMBER 13, 2023
Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries has entered into a license agreement with Pharmazz, a US based biopharma company to commercialise a first-in-class drug, Tyvalzi (Sovateltide) in India. Developed by Pharmazz for potential global use, Sovateltide is indicated for treating cerebral ischemic stroke. As per agreement terms, Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide).
pharmaphorum
SEPTEMBER 13, 2023
EU clears review of Xtandi in earlier-stage prostate cancer Phil.
Pharmafile
SEPTEMBER 13, 2023
LimFlow SA has announced that the US Food and Drug Administration (FDA) has approved its LimFlow System for the treatment of patients with chronic limb-threatening ischemia (CLTI) who have no other suitable endovascular or surgical treatment options and are otherwise facing major amputation. The LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is intended […] The post FDA approves LimFlow system for patients with CLTI appeared first on Pharmafile.
pharmaphorum
SEPTEMBER 13, 2023
Pitango partner talks new $175M health tech fund, AI, and rocky markets Nicole.
Pharmafile
SEPTEMBER 13, 2023
Clinical stage biopharmaceutical company Nuvectis Pharma has announced the initiation of a phase 1a dose escalation clinical study of NXP900, a novel inhibitor of the SRC/YES1 kinase family (SFK). The study is intended to assess the drug’s safety, tolerability and pharmacokinetics in patients with advanced solid tumours. NXP900 is a highly selective SFK inhibitor which […] The post Nuvectis Pharma initiates phase 1a NXP900 clinical trial appeared first on Pharmafile.
pharmaphorum
SEPTEMBER 13, 2023
Oral phenylephrine vote may see OTC products pulled in US Phil.
Digital Pharmacist
SEPTEMBER 13, 2023
Pharmacies play a crucial role in healthcare by ensuring patients receive the right medications and proper guidance on their usage. Medication Therapy Management (MTM) services are essential for improving patient outcomes and medication adherence. To optimize these services and enhance patient engagement, pharmacies can leverage technology in various ways, from appointment scheduling and two-way messaging to outbound calling, pharmacy websites, and social media.
Pharmacy Joe
SEPTEMBER 13, 2023
In this episode, I’ll discuss a study about the safety of apixaban in patients with renal insufficiency. Episode 852: Does Europe Do Apixaban Renal Dosing Better (Safer) Than the US? Subscribe on iTunes , Android , or Stitcher The US FDA and the European Medicines Agency have discordant recommendations for apixaban dosing in chronic kidney disease.
epicur
SEPTEMBER 13, 2023
When ordering a patient’s medication, the traditional mindset in veterinary medicine is to be as exact as possible. This results in requests for precise dosages such as 1.22 milligrams or other 0.1 levels. Because patient care is the top priority, it’s common to trust that exact strengths are the best course of treatment. However, the more closely we look at what it takes to compound an exact strength, the clearer it becomes standard dosages are more beneficial to both patients and veterinary pr
PharmaTech
SEPTEMBER 13, 2023
Rentschler Biopharma’s ATMP business can now offer its full range of services for the clinical supply of AAV, including bioprocess and analytical development through to cGMP manufacturing at the Stevenage facility in the UK.
Putting Patients First Blog
SEPTEMBER 13, 2023
Chief Financial Leads Affinity Group Meeting: NHC 2022 Annual Revenue Report Summary Discussion Event Time: 3:00 - 3:45 p.m. ET Event Location: Virtual Home Register Schedule (Coming Soon) Speakers (Coming Soon) Event Policies CAE Credits About the Event The NHC Membership and Finance Teams invite the finance and executive leadership from our Patient Organization (PO)/Voluntary Health Agency (VHA) members to join us for an overview of the 2022 Revenue Report Findings and a discussion about the r
Expert insights. Personalized for you.
353 
Let's personalize your content